These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 25641229)

  • 21. Molecular mechanisms underlying the tetrandrine-mediated reversal of the fluconazole resistance of Candida albicans.
    Zhang X; Guo H; Gao L; Song Y; Li S; Zhang H
    Pharm Biol; 2013 Jun; 51(6):749-52. PubMed ID: 23527892
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The roles of CDR1, CDR2, and MDR1 in kaempferol-induced suppression with fluconazole-resistant Candida albicans.
    Shao J; Zhang M; Wang T; Li Y; Wang C
    Pharm Biol; 2016; 54(6):984-92. PubMed ID: 26459663
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relative contributions of the Candida albicans ABC transporters Cdr1p and Cdr2p to clinical azole resistance.
    Tsao S; Rahkhoodaee F; Raymond M
    Antimicrob Agents Chemother; 2009 Apr; 53(4):1344-52. PubMed ID: 19223631
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Role of Ergosterol and Sphingolipids in the Localization and Activity of
    Urbanek AK; Muraszko J; Derkacz D; Łukaszewicz M; Bernat P; Krasowska A
    Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077373
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activity of Isavuconazole and Other Azoles against Candida Clinical Isolates and Yeast Model Systems with Known Azole Resistance Mechanisms.
    Sanglard D; Coste AT
    Antimicrob Agents Chemother; 2016 Jan; 60(1):229-38. PubMed ID: 26482310
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rationally designed transmembrane peptide mimics of the multidrug transporter protein Cdr1 act as antagonists to selectively block drug efflux and chemosensitize azole-resistant clinical isolates of Candida albicans.
    Maurya IK; Thota CK; Verma SD; Sharma J; Rawal MK; Ravikumar B; Sen S; Chauhan N; Lynn AM; Chauhan VS; Prasad R
    J Biol Chem; 2013 Jun; 288(23):16775-16787. PubMed ID: 23592791
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overexpression of Candida albicans CDR1, CDR2, or MDR1 does not produce significant changes in echinocandin susceptibility.
    Niimi K; Maki K; Ikeda F; Holmes AR; Lamping E; Niimi M; Monk BC; Cannon RD
    Antimicrob Agents Chemother; 2006 Apr; 50(4):1148-55. PubMed ID: 16569823
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fungicidal synergism of fluconazole and cyclosporine in Candida albicans is not dependent on multidrug efflux transporters encoded by the CDR1, CDR2, CaMDR1, and FLU1 genes.
    Marchetti O; Moreillon P; Entenza JM; Vouillamoz J; Glauser MP; Bille J; Sanglard D
    Antimicrob Agents Chemother; 2003 May; 47(5):1565-70. PubMed ID: 12709323
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of Farnesol as a Modulator of Efflux Pumps in a Fluconazole-Resistant Strain of
    Černáková L; Dižová S; Gášková D; Jančíková I; Bujdáková H
    Microb Drug Resist; 2019; 25(6):805-812. PubMed ID: 30785845
    [No Abstract]   [Full Text] [Related]  

  • 30. The monoamine oxidase A inhibitor clorgyline is a broad-spectrum inhibitor of fungal ABC and MFS transporter efflux pump activities which reverses the azole resistance of Candida albicans and Candida glabrata clinical isolates.
    Holmes AR; Keniya MV; Ivnitski-Steele I; Monk BC; Lamping E; Sklar LA; Cannon RD
    Antimicrob Agents Chemother; 2012 Mar; 56(3):1508-15. PubMed ID: 22203607
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanism of fluconazole resistance in Candida albicans biofilms: phase-specific role of efflux pumps and membrane sterols.
    Mukherjee PK; Chandra J; Kuhn DM; Ghannoum MA
    Infect Immun; 2003 Aug; 71(8):4333-40. PubMed ID: 12874310
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vanillin confers antifungal drug synergism in Candida albicans by impeding CaCdr2p driven efflux.
    Saibabu V; Fatima Z; Singh S; Khan LA; Hameed S
    J Mycol Med; 2020 Apr; 30(1):100921. PubMed ID: 31937429
    [TBL] [Abstract][Full Text] [Related]  

  • 33. FLO8 deletion leads to azole resistance by upregulating CDR1 and CDR2 in Candida albicans.
    Li WJ; Liu JY; Shi C; Zhao Y; Meng LN; Wu F; Xiang MJ
    Res Microbiol; 2019; 170(6-7):272-279. PubMed ID: 31449848
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanisms of azole resistance in Candida albicans clinical isolates from Shanghai, China.
    Liu JY; Shi C; Wang Y; Li WJ; Zhao Y; Xiang MJ
    Res Microbiol; 2015 Apr; 166(3):153-61. PubMed ID: 25748216
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New evidence that Candida albicans possesses additional ATP-binding cassette MDR-like genes: implications for antifungal azole resistance.
    Walsh TJ; Kasai M; Francesconi A; Landsman D; Chanock SJ
    J Med Vet Mycol; 1997; 35(2):133-7. PubMed ID: 9147273
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synergic effects of tactolimus and azole antifungal agents against azole-resistant Candida albican strains.
    Maesaki S; Marichal P; Hossain MA; Sanglard D; Vanden Bossche H; Kohno S
    J Antimicrob Chemother; 1998 Dec; 42(6):747-53. PubMed ID: 10052898
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antifungal effect of Echinophora platyloba on expression of CDR1 and CDR2 genes in fluconazole-resistant Candida albicans.
    Khajeh E; Hosseini Shokouh SJ; Rajabibazl M; Roudbary M; Rafiei S; Aslani P; Farahnejad Z
    Br J Biomed Sci; 2016; 73(1):44-8. PubMed ID: 27182677
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Investigation of fluconazole susceptibility to Candida albicans by MALDI-TOF MS and real-time PCR for CDR1, CDR2, MDR1 and ERG11.
    Maenchantrarath C; Khumdee P; Samosornsuk S; Mungkornkaew N; Samosornsuk W
    BMC Microbiol; 2022 Jun; 22(1):153. PubMed ID: 35689195
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of magnolol and honokiol on adhesion, yeast-hyphal transition, and formation of biofilm by Candida albicans.
    Sun L; Liao K; Wang D
    PLoS One; 2015; 10(2):e0117695. PubMed ID: 25710475
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Spectrum of activity and mechanisms of azole-bisphosphonate synergy in pathogenic
    Kane A; Dinh H; Campbell L; Cain AK; Hibbs D; Carter D
    Microbiol Spectr; 2024 Jun; 12(6):e0012124. PubMed ID: 38695556
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.